MedTrace Logo

Smartphone-Delivered Attentional Bias Modification Training in Helping Patients Quit Smoking

NCT02224391 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 311

Last updated 2023-03-07

Study results available
· View outcomes & findings →

Summary

This randomized clinical trial studies how well a smartphone-delivered attentional bias modification training works in helping patients quit smoking. Smartphone-delivered attentional bias modification training may help patients quit smoking by reducing the attentional bias (the tendency of one's perception to be affected by their recurring thoughts) towards smoking cues that developed over time as a result of conditioning processes through which smoking cues become important.

Conditions

  • Current Every Day Smoker

Interventions

BEHAVIORAL

Computer-Assisted Smoking Cessation Intervention

Receive ABM training via a smartphone

OTHER

Laboratory Biomarker Analysis

Correlative studies

DRUG

Nicotine Patch

Given via transdermal patch

OTHER

Questionnaire Administration

Ancillary studies

OTHER

Sham Intervention

Undergo sham training

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Jason Robinson, MD · M.D. Anderson Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-20
Primary Completion
2021-03-15
Completion
2021-03-15
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02224391 on ClinicalTrials.gov